•
IB
IBIO
iBio, Inc. Common Stock
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
50.37M
Volume
1.23M
52W High
$6.89
52W Low
$0.56
Open
$0.00
Prev Close
$2.24
Day Range
0.00 - 0.00
About iBio, Inc. Common Stock
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Latest News
iBio Announces $26 Million Private Placement
GlobeNewswire Inc.•Jan 9
iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
GlobeNewswire Inc.•Oct 23
iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results
GlobeNewswire Inc.•Jun 24
iBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBio
GlobeNewswire Inc.•Jan 2
Biopharmaceuticals Contract Manufacturing Industry Research 2024-2030: Biopharma Giants Increasingly Outsource to Streamline Drug Developments
GlobeNewswire Inc.•Oct 14
iBio to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.•Sep 3
iBio Closes Sale of Manufacturing Facility in Texas
GlobeNewswire Inc.•Jun 3
iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire Inc.•May 13